On January 14, Accenture’s chief executive officer, Mauro Macchi, sold 500 shares of company stock in a single transaction valued at $140,000. Following the sale, Macchi’s total holdings declined from 7,623 to 7,123 shares, a 6.56% reduction. The remaining stake is now valued at approximately $1.99 million based on the transaction price. The sale was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission, highlighting ongoing insider liquidity activity at the firm’s executive level.

Also on January 14, Accenture’s president and CEO, Julie Spellman Sweet, sold 1,694 shares of the company’s common stock for total proceeds of $488,380.20. This disposal represents a 4.34% decrease in her personal position, reducing her holdings to 37,346 shares valued at roughly $10.77 million post-transaction. Over the past three months, insiders at Accenture have sold a combined 40,076 shares, generating proceeds of more than $10.25 million, signaling increased insider turnover as the company enters its new fiscal year.

In its fiscal second quarter results issued December 18, Accenture reported earnings per share of $3.94, outperforming the analyst consensus by $0.21. Quarterly revenue reached $18.74 billion, topping expectations by $0.23 billion and marking a 5.7% increase year-over-year. Net margin stood at 10.76% while return on equity reached 26.65%. For fiscal 2026, the company provided EPS guidance in a range of 13.520 to 13.900, compared with the current consensus forecast of 12.73 earnings per share for the full year.

Accenture declared a quarterly dividend of $1.63 per share, payable February 13 to shareholders of record January 13, representing an annualized payout of $6.52 and a yield of 2.3%. The dividend payout ratio stands at 53.88%. On the sell-side, one firm holds a Strong Buy rating, seventeen recommend Buy, eleven advise Hold and one rates the stock as Sell, yielding a consensus Moderate Buy rating and an average price target of $297.20. Institutional investors and hedge funds collectively own 75.14% of the outstanding shares, reflecting broad professional-market confidence in Accenture’s growth prospects.